Blueprint Medicines Corp


Market Cap$6.66B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Blueprint Medicines CorpBlueprint Medicines Corp-23.10%-93%26.30.8

Target Price by Analysts

6.5% upsideBlueprint Medicines Target Price DetailsTarget Price

Current Fair Value

9.3% downside

Overvalued by 9.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.66 Billion
Enterprise Value$6.25 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-4.69
Outstanding Shares62,616,902
Avg 30 Day Volume492,468


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-23.11
Price to Sales26.3
Price to Book Ratio26.3
Enterprise Value to Revenue22.16
Enterprise Value to EBIT-14.28
Enterprise Value to Net Income-22
Total Debt to Enterprise0.04
Debt to Equity0.77

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Blueprint Medicines Corp

CEO: Jeffrey Albers